Vascular Anatomy, Embryology, Hemodynamics, and Venous/Lymphatic Physiology
Vascular anatomy becomes clinically useful when a named structure is translated into pressure delivery, resistance control, exchange, capacitance, venous return, or lymphatic drainage. This chapter builds the shared physiology used later for arterial testing, imaging, operative anatomy, chronic venous disease, lymphedema, and dialysis access.
Foundations explainer: Build from mechanisms and physiology toward clinical consequences with calm explanatory pacing.
General medical education, not patient-specific advice.
Choose the hostsVascular function and wall biology
Vascular structures are defined by their physiological roles rather than purely by their anatomical names. Elastic and muscular arteries deliver pressure and pulsatile flow; arterioles determine small-vessel resistance; capillaries provide the exchange surface; veins act as capacitance and return conduits; and lymphatics clear interstitial fluid while participating in immune traffic and lipid transport . Operative capability depends on the media, adventitia, valves, vasa vasorum, surrounding fascia, and collateral branches accommodating clamp application, puncture, endarterectomy, or high-pressure remodeling .
Vessel networks result from vasculogenesis, angiogenesis, and lymphangiogenesis. Upper-limb arterial variations, including brachial, radial, ulnar, and interosseous patterns, reflect the variable sequence of embryonic channel remodeling rather than a fixed anatomical arrangement . Endothelial identity is structurally specialized and mechanosensitive. Arterial endothelium relies on Notch and ephrin-B2 signaling; venous endothelium is directed by EphB4 and COUP-TFII programs; and lymphatic endothelium uses PROX1 and VEGF-C/VEGFR3 biology .
Hemodynamics and mechanotransduction
A measured velocity, pressure drop, or angiographic narrowing has clinical meaning only when correlated with total flow, resistance, compliance, collateral supply, and the receiving vascular bed . Local vessel geometry dictates the distribution of disease and remodeling. Curves, bifurcations, branch points, and anastomoses create non-uniform shear fields. Flow separation, recirculation, low shear, and oscillatory shear localize reliably to the carotid bulb, the infrarenal aorta, the iliac bifurcation, and the heel and toe of vascular anastomoses .
Disturbed flow alters endothelial cellular programming, driving focal intimal thickening, plaque formation, or anastomotic hyperplasia . Endothelial cells sense fluid shear and cyclic stretch through junctional complexes involving PECAM-1, VE-cadherin, and VEGF receptor signaling, linked directly to cytoskeletal and cell-matrix pathways . Diagnostic surrogates operate on these same physical principles. A duplex velocity reflects local acceleration and narrowing, and its interpretation relies on inflow, outflow, compliance, and specific conduit properties. The ankle-brachial index connects systemic pressure to distal limb pressure, providing diagnostic and prognostic stratification for peripheral artery disease . A resting ABI of 1.00 to 1.40 is normal, 0.91 to 0.99 is borderline, and 0.90 or below is diagnostic of PAD; a value above 1.40 marks a non-compressible, medially calcified vessel and forces reliance on the toe-brachial index instead. An ABI at or below 0.90 is independently prognostic for cardiovascular events, not merely a marker of limb ischemia.
Venous and lymphatic physiology
Venous and lymphatic networks are active, low-pressure return systems. Veins operate as compliant reservoirs governed by valves, calf muscle pump function, respiratory variation, and central venous pressure . Lymphatic initial networks absorb interstitial fluid and macromolecules, advancing lymph through valved collecting segments driven by pressure gradients, extrinsic compression, and intrinsic lymphangion contraction .
Lymphatic propulsion is actively paced and tuned. Chronic edema results from inadequate propulsion, adverse loading, or vessel remodeling, rather than a single fixed obstruction . Valve maturation and flow-sensitive remodeling are essential for maintaining directionality in both systems .
Developmental and genetic overlap explains concurrent venous and lymphatic dysfunction. Lymphatic endothelial identity arises via PROX1-driven differentiation from venous endothelium, supported by VEGF-C/VEGFR3 signaling . Shared developmental pathways, including FOXC2, PROX1, and VEGF-C, coordinate both venous and lymphatic valve formation .
Diagnostic interpretation of vascular and lymphatic findings
Vascular assessment isolates the specific functional defect before selecting an anatomical intervention. Peripheral edema is evaluated by determining whether venous pressure is high, venous return is obstructed, reflux overloads the microcirculation, or lymphatic clearance is insufficient . The CEAP classification standardizes the recording of clinical class, etiology, anatomy, and pathophysiology to isolate the specific mechanism driving chronic venous disease . The clinical axis runs C0 no visible or palpable venous disease; C1 telangiectasias or reticular veins; C2 varicose veins; C3 edema; C4 skin and subcutaneous change, subdivided into C4a pigmentation or eczema, C4b lipodermatosclerosis or atrophie blanche, and C4c corona phlebectatica; C5 healed venous ulcer; and C6 active venous ulcer. The 2020 revision adds the suffix r to denote recurrence at C2 and C6. The International Society of Lymphology staging similarly categorizes the progression of lymphatic dysfunction from subclinical fluid retention to established fibroadipose tissue remodeling . Its stages run Stage 0, latent transport impairment without overt swelling; Stage I, early pitting edema that recedes with elevation; Stage II, edema that no longer resolves with elevation alone, with tissue fibrosis in late Stage II where pitting may be lost; and Stage III, lymphostatic elephantiasis with non-pitting swelling, trophic skin change, and fibroadipose deposition.
| Clinical finding | Physiological variable | Diagnostic interpretation | Citation |
|---|---|---|---|
| Arterial stenosis or occlusion | Pressure delivery, resistance, and collateral flow | Interpret structural narrowing alongside downstream bed perfusion and flow reserve | |
| Duplex velocity acceleration | Local vessel geometry, compliance, and flow dynamics | Correlate with downstream symptoms and specify native vessel versus synthetic or biological conduit | |
| Edema with varicosities or skin changes | Venous reflux, obstruction, or calf-pump failure | Apply CEAP classification to isolate the etiology and pathophysiology | |
| Chronic swelling with tissue remodeling | Lymphatic filtration mismatch or intrinsic pump failure | Apply ISL staging to distinguish reversible fluid from non-pitting fibroadipose change |
- Physiological variable
- Pressure delivery, resistance, and collateral flow
- Diagnostic interpretation
- Interpret structural narrowing alongside downstream bed perfusion and flow reserve
- Citation
- Physiological variable
- Local vessel geometry, compliance, and flow dynamics
- Diagnostic interpretation
- Correlate with downstream symptoms and specify native vessel versus synthetic or biological conduit
- Citation
- Physiological variable
- Venous reflux, obstruction, or calf-pump failure
- Diagnostic interpretation
- Apply CEAP classification to isolate the etiology and pathophysiology
- Citation
- Physiological variable
- Lymphatic filtration mismatch or intrinsic pump failure
- Diagnostic interpretation
- Apply ISL staging to distinguish reversible fluid from non-pitting fibroadipose change
- Citation
Areas of controversy
The pathophysiology of chronic lymphedema is debated, specifically regarding whether it is primarily a mechanical obstruction disorder or an active failure of mechanosensory pacemaking, lymphatic vessel remodeling, and dynamic interstitium interactions . The relative contribution of intrinsic lymphangion failure versus extrinsic structural blockage continues to define investigative therapeutic targets for chronic swelling .
References
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
- 9.
- 10.
- 11.
- 12.
- 13.
- 14.
- 15.2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 2017.PubMed-indexed articleClinical practice guideline2016
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 2017. doi:10.1161/cir.0000000000000470.
- 16.Editor's Choice – European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. 2022.PubMed-indexed articleClinical practice guideline2022
Editor's Choice – European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. 2022. doi:10.1016/j.ejvs.2021.12.024.
- 17.
- 18.
- 19.
- 20.
- 21.
- 22.
- 23.
- 24.
- 25.
- 26.THE DIAGNOSIS AND TREATMENT OF PERIPHERAL LYMPHEDEMA: 2020 CONSENSUS DOCUMENT OF THE INTERNATIONAL SOCIETY OF LYMPHOLOGY. 2020.PubMed-indexed articleClinical practice guideline2020
THE DIAGNOSIS AND TREATMENT OF PERIPHERAL LYMPHEDEMA: 2020 CONSENSUS DOCUMENT OF THE INTERNATIONAL SOCIETY OF LYMPHOLOGY. 2020. doi:10.2458/lymph.4649.
Educational use only
AI assists this editorial workflow. Published updates are human-reviewed before publication.
Not intended to diagnose, monitor, predict, prognose, treat, or alleviate disease.
Verify clinically relevant information against primary sources and current guidelines.